Tech and labor organizations are trying out a upskilling plus monthly stipend program to prepare for the potential of mass ...

RESPONSE FROM IOWA DEMOCRATS TONIGHT ON THE NEWS AT TEN, THE CITY OF DES MOINES SAYS THE 515 RUN CLUB NEEDS A PERMIT TO KEEP RUNNING AT A CITY PARK. THE FREE AND INFORMAL RUNNING GROUP HAS MET ...

The Q&A has ended. Click here to read the answers to your questions. If you’re an app user, click on the comments icon on the top right of your screen. As the weather is starting to get better, more ...

FILE - Voting booths are set up at a polling place in Newtown, Pa., Tuesday, April 23, 2024. (AP Photo/Matt Rourke, File) From Philly and the Pa. suburbs to South Jersey and Delaware, what would you ...

Collins, who appeared on Jason Tartick's podcast “Trading Secrets,” looked back on her time working at the White House while covering Trump's administration. "Sometimes presidents are press-averse; ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The Department of Homeland Security (DHS) said that it has restored the ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

State lawmakers might reduce funding for Running Start, a program that lets high school juniors and seniors take courses and earn credits at community and technical colleges. Running Start students ...

As funds begin flowing to states through the five-year, $50 billion Rural Health Transformation Program, hospital leaders are confronting a central question: Will the initiative meaningfully stabilize ...

Farm management analyst Kent Thiesse answers some of the farm program and crop insurance questions that have resulted from the implementation of the One Big Beautiful Bill Act. Some of the farm ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.